发明名称 |
Bacteriophages |
摘要 |
The present invention provides a bacteriophage with effective antibacterial activity against Staphylococcus strains and in particular MRSA. There is also provided a pharmaceutical composition comprising said bacteriophage and a method of treating a bacterial infection using a composition comprising said bacteriophage. |
申请公布号 |
US9623058(B2) |
申请公布日期 |
2017.04.18 |
申请号 |
US201214356869 |
申请日期 |
2012.11.07 |
申请人 |
Ampliphi Biosciences Corporation |
发明人 |
Jia Ying |
分类号 |
A61K35/76;C12N7/00;A61K9/00 |
主分类号 |
A61K35/76 |
代理机构 |
|
代理人 |
|
主权项 |
1. A Staphylococcus bacteriophage K mutant, which comprises one or more mutations within one or more of the following regions, corresponding to the nucleotide sequence of wild-type Staphylococcus bacteriophage K, selected from:
a) the region between ORF 18 and ORF 19; and/or b) the region between ORF 41 and ORF 42; and/or c) ORF 68; and/or d) an overlapping region within ORF 86/88/90; and/or e) ORF 92; and/or f) ORF 93; and/or g) ORF 96; and/or h) ORF 100. |
地址 |
Richmond VA US |